论文部分内容阅读
自EHF病毒分离成功以来,病原学、特异性诊断、流行病学等方面的研究进展较快,但对病人的治疗尚无特效药物。为此,安徽省医学科学研究所和阜阳地区出血热防治研究所根据近年来对EHF的免疫机理的研究以及临床应用人转移因子治疗EHF似有一定疗效的报道,于1985年应用乳鼠直接分离的EHF病毒(A-537株)免疫猪后,用其脾脏制备出抗EHF转移因子,治疗EHF早期病人13例。据初步观察结果表明,具有一定的疗效。
Since the successful separation of EHF virus, etiology, specific diagnosis, epidemiology and other aspects of the research progress is rapid, but the treatment of patients with no specific drugs. To this end, Anhui Institute of Medical Sciences and Fuyang hemorrhagic fever prevention and cure Institute in recent years on the immune mechanism of EHF and clinical application of human transfer factor treatment of EHF seems to have a certain effect reported in 1985, the application of direct isolation of suckling mice Of EHF virus (A-537 strain) immunized pigs, with its spleen prepared anti-EHF transfer factor in the treatment of 13 cases of early EHF patients. According to preliminary observations show that, with a certain effect.